Company Search:
Advanced Search
Sponsored Links
Nektar Therapeutics Company Snapshot
Nektar Therapeutics operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nektar Therapeutics with three other companies in this sector in the United States: Amphastar Pharmaceuticals Inc (2015 sales of $251.52 million of which 89% was Pharmaceutical), Aegerion Pharmaceuticals Incorporation ($239.89 million of which 100% was Biopharmaceutical), and Pacira Pharmaceuticals Inc ($249.00 million of which 100% was Depo Foam Drug Delivery Technology).

Sales Analysis. During the year ended December of 2015, sales at Nektar Therapeutics were $230.78 million. This is an increase of 15.0% versus 2014, when the company's sales were $200.71 million. This was the fourth straight year of sales growth at Nektar Therapeutics.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nektar Therapeutics
  Stock Performance Chart for Nektar Therapeutics
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 15.89
(Figures in U.S. Dollars)
1 Week -5.5%   13 Weeks -16.7%  
4 Weeks 2.8%   52 Weeks 46.0%  
Nektar Therapeutics Key Data:
  Ticker: NKTR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 230,784,000
(Year Ending Jan 2016).
Employees: 435
  Currency: U.S. Dollars Market Cap: 2,172,678,631
  Fiscal Yr Ends: December Shares Outstanding: 136,732,450
  Share Type: Common Closely Held Shares: 695,295
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.